Literature DB >> 16081037

Role of GPR40 in fatty acid action on the beta cell line INS-1E.

Hagit Shapiro1, Sigal Shachar, Israel Sekler, Michal Hershfinkel, Michael D Walker.   

Abstract

GPR40 is a G protein-coupled receptor expressed preferentially in beta cells, that has been implicated in mediating free fatty acid-stimulated insulin release. GPR40 RNAi impaired the ability of palmitic acid (PA) to increase both insulin secretion and intracellular calcium ([Ca2+]i). The PA-dependent [Ca2+]i increase was attenuated by inhibitors of Galphaq, PLC, and SERCA. Thus GPR40 activates the Galphaq pathway, leading to release of Ca2+ from the ER. Yet the GPR40-dependent [Ca2+]i rise was dependent on extracellular Ca2+ and elevated glucose, and was blocked by inhibition of L-type calcium channels (LTCC) or opening of the K(ATP) channel; this suggests that GPR40 promotes Ca2+ influx through up-regulation of LTCC pre-activated by glucose and membrane depolarization. Taken together, the data indicate that GPR40 mediates the increase in [Ca2+]i and insulin secretion through the Galphaq-PLC pathway, resulting in release of Ca2+ from the ER and leading to up-regulation of Ca2+ influx via LTCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081037     DOI: 10.1016/j.bbrc.2005.07.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  58 in total

1.  GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins.

Authors:  Keren Bahar Halpern; Anna Veprik; Nir Rubins; Orly Naaman; Michael D Walker
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 2.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

3.  Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.

Authors:  Celia P Briscoe; Andrew J Peat; Stephen C McKeown; David F Corbett; Aaron S Goetz; Thomas R Littleton; David C McCoy; Terry P Kenakin; John L Andrews; Carina Ammala; James A Fornwald; Diane M Ignar; Stephen Jenkinson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

Review 4.  Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.

Authors:  Stefano Costanzi; Susanne Neumann; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

Review 5.  Physiological effects of nutrients on insulin release by pancreatic beta cells.

Authors:  Monica Losada-Barragán
Journal:  Mol Cell Biochem       Date:  2021-04-12       Impact factor: 3.396

6.  Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist.

Authors:  Rieko Takano; Masao Yoshida; Masahiro Inoue; Takeshi Honda; Ryutaro Nakashima; Koji Matsumoto; Tatsuya Yano; Tsuneaki Ogata; Nobuaki Watanabe; Masakazu Hirouchi; Tomoko Yoneyama; Shuichiro Ito; Narihiro Toda
Journal:  ACS Med Chem Lett       Date:  2015-01-13       Impact factor: 4.345

7.  Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.

Authors:  Nobuyuki Negoro; Shinobu Sasaki; Satoshi Mikami; Masahiro Ito; Masami Suzuki; Yoshiyuki Tsujihata; Ryo Ito; Ayako Harada; Koji Takeuchi; Nobuhiro Suzuki; Junichi Miyazaki; Takashi Santou; Tomoyuki Odani; Naoyuki Kanzaki; Miyuki Funami; Toshimasa Tanaka; Akifumi Kogame; Shinichiro Matsunaga; Tsuneo Yasuma; Yu Momose
Journal:  ACS Med Chem Lett       Date:  2010-06-18       Impact factor: 4.345

8.  β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.

Authors:  Arturo D Mancini; Gyslaine Bertrand; Kevin Vivot; Éric Carpentier; Caroline Tremblay; Julien Ghislain; Michel Bouvier; Vincent Poitout
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

9.  Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11.

Authors:  S Dhayal; H J Welters; N G Morgan
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

10.  Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.

Authors:  Thierry Alquier; Marie-Line Peyot; Martin G Latour; Melkam Kebede; Christina M Sorensen; Stephane Gesta; C Ronald Kahn; Richard D Smith; Thomas L Jetton; Thomas O Metz; Marc Prentki; Vincent Poitout
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.